OVERVIEW

Oncology Pharmacists Connect (OPC) 2025 is organized by Pharmacy Times Continuing Education (PTCE), Hematology/Oncology Pharmacy Association (HOPA) and will be held from Jun 19 - 20, 2025 at Omni Austin Hotel Downtown, Austin, Texas, United States of America.

Description:
The complexity of new regimens and the need for coordination of care across practice and pharmacy settings has reinforced and expanded the roles of oncology pharmacists. This conference is designed for oncology pharmacists to meet as a larger ecosystem of pharmacists working together to identify and develop solutions for responding clinically and operationally to rapidly evolving evidence reported at the 2025 ASCO Annual Meeting. The program agenda facilitates bringing pharmacists focused on cancer care from multiple types of practice settings together to discuss recently presented data, identify resources needed to successfully implement new therapies and make formulary decisions, examine challenges, and brainstorm solutions to meet organizational demands while improving patient outcomes. The core meeting will be composed of accredited continuing education sessions, highlighting the most impactful ASCO abstracts from each disease state delivered as panel discussions to enable debate, discussion, and collaborative peer-exchange.

Core sessions include:

hematologic malignancies, multiple myeloma, leukemia/lymphoma, genitourinary, gastrointestinal, cutaneous, thoracic, and breast cancers as well as delivery and quality of oncology care.
Analyze recent clinical updates on novel and emerging pharmacotherapeutic approaches for solid and hematologic malignancies presented at the 2025 American Society of Clinical Oncology Annual Meeting
Explain the impact of recent evidence to multiple disease treatment paradigms and challenges to implementation of evolving therapies
Apply operational and managed care considerations for the evaluation and integration of changes through formulary decisions, pathways, and resource allocation.